ライフサイエンスコーパス: peripheral blood lymphocyte

1 ytes; high-load carriers, >200 genomes/10(5) peripheral blood lymphocytes).

2 abundant (>1% of total MHC-I transcripts in peripheral blood lymphocytes).

3 ed significant with <0.05% memory B cells in peripheral blood lymphocytes.

4 uman endogenous retrovirus was isolated from peripheral blood lymphocytes.

5 f CD4+CD25+ T cells when cultured with human peripheral blood lymphocytes.

6 th determination of basal H(2)O(2) levels in peripheral blood lymphocytes.

7 erosis have been largely confined to testing peripheral blood lymphocytes.

8 pithelial cells, T lymphocyte cell lines, or peripheral blood lymphocytes.

9 ons (including dicentrics and ring forms) in peripheral blood lymphocytes.

10 ed similar results using RNA interference in peripheral blood lymphocytes.

11 thelial lymphocytes and on a small subset of peripheral blood lymphocytes.

12 approximately 30 cells/microl) of the total peripheral blood lymphocytes.

13 ing receptor profile similar to untransduced peripheral blood lymphocytes.

14 2ME2 does not reduce the survival of normal peripheral blood lymphocytes.

15 tacrolimus were studied using purified human peripheral blood lymphocytes.

16 ic genotypes after costimulation of cultured peripheral blood lymphocytes.

17 e-B lymphoma L1.2 cells, Jurkat T cells, and peripheral blood lymphocytes.

18 expressed RE transcripts between the OFC and peripheral blood lymphocytes.

19 apoptosis were compared in elephant vs human peripheral blood lymphocytes.

20 re sufficiently high to induce chemotaxis of peripheral blood lymphocytes.

21 n measurements in surrogate tissues, such as peripheral blood lymphocytes.

22 d p16 mutations identified in DNA from their peripheral blood lymphocytes.

23 ct persistent LCV infection in rhesus monkey peripheral blood lymphocytes.

24 fluids, including serum, saliva, urine, and peripheral blood lymphocytes.

25 the VHL-gene mutation in a portion of their peripheral blood lymphocytes.

26 , cpm-1285 had little effect on normal human peripheral blood lymphocytes.

27 and is observed predominantly in testis and peripheral blood lymphocytes.

28 l-free assays and viral replication in human peripheral blood lymphocytes.

29 ponse to IL-2 in both T-cell lines and human peripheral blood lymphocytes.

30 mune-deficient mice reconstituted with human peripheral blood lymphocytes.

31 sequences are transcriptionally abundant in peripheral blood lymphocytes.

32 lymphocyte co-cultures between normal human peripheral blood lymphocytes, (1) frequencies of memory

33 ave been observed to be induced in activated peripheral blood lymphocytes, a cell type relevant to HI

34 d blood lymphocytes (CBL) compared to adult (peripheral) blood lymphocytes (ABL).

35 s by injecting inferior lacrimal glands with peripheral blood lymphocytes activated by 5 days of cocu

36 and then transcriptomes from single cells of peripheral blood lymphocytes activated by a Mycobacteriu

37 Autologous peripheral blood lymphocytes, activated in a mixed-cell

38 >40 cases of primary cells, including normal peripheral blood lymphocytes, acute lymphoblastic leukem

39 ns and in the tissue culture supernatants of peripheral blood lymphocytes after stimulation.

40 ho developed persistent virus loads in their peripheral blood lymphocytes after transplantation.

41 units/106 cells) was documented in quiescent peripheral blood lymphocytes after treatment initiated b

42 t Vbeta restriction was found using the same peripheral blood lymphocytes against a different haploty

43 trate different, but stable, levels of donor peripheral blood lymphocyte and granulocyte chimerism.

44 Peripheral blood lymphocyte and urine DNA obtained from

45 shortening in CHD is restricted to specific peripheral blood lymphocyte and/or myeloid cell subpopul

46 e intracellular growth of M. tuberculosis by peripheral blood lymphocytes and antigen-specific CD4+ T

47 rferon enzyme-linked immunospot assays using peripheral blood lymphocytes and autologous CD1(+) immat

48 envelope-specific gamma interferon-secreting peripheral blood lymphocytes and better priming of T-cel

49 Infections of peripheral blood lymphocytes and certain cell lines were

50 rotein levels are induced in activated human peripheral blood lymphocytes and CycT1 protein levels ar

51 Serum and CVL were incubated with normal peripheral blood lymphocytes and HIV-1 gp120-bearing tar

52 we observed that exposure in vitro of normal peripheral blood lymphocytes and human bone marrow-deriv

53 ere isolated 1 year postoperatively from the peripheral blood lymphocytes and iliac crest bone marrow

54 fibronectin induced Vav1 phosphorylation in peripheral blood lymphocytes and in two different T cell

55 on, yields enhanced rolling ligands for both peripheral blood lymphocytes and Jurkat cells in flow ch

56 Tat delayed FasL-mediated apoptosis in both peripheral blood lymphocytes and Jurkat cells, as it is

57 Phenotypic analysis of peripheral blood lymphocytes and mixed lymphocyte reacti

58 We have found that treatment of peripheral blood lymphocytes and purified resting CD4(+)

59 ved from phytohemagglutinin (PHA) stimulated peripheral blood lymphocytes and radiation hybrid mappin

60 his hypothesis, we obtained matched pairs of peripheral blood lymphocytes and serum specimens simulta

61 Analyses of peripheral blood lymphocytes and serum suggested that PO

62 AW and PW enhanced HIV infection of peripheral blood lymphocytes and T-cell lines (Jurkat an

63 xtent, IL-7 enhance the expression of A3G in peripheral blood lymphocytes and that this effect is blo

64 Both the mean frequencies of donor-reactive peripheral blood lymphocytes and the number of individua

65 nduction of neuropeptide substance P in both peripheral blood lymphocytes and the T-cell lines.

66 ound to be expressed on the surface of human peripheral blood lymphocytes and transformed B- and T-ly

67 Flow cytometry was used to analyze peripheral-blood lymphocytes and bone marrow aspirates.

68 rapy, rabbit ATG is more potent in depleting peripheral-blood lymphocytes and is preferred in other c

69 deficient mice were reconstituted with human peripheral blood lymphocytes, and encephalitis was induc

70 ere defined arbitrarily as >25 spots/300,000 peripheral blood lymphocytes, and positive PRT was defin

71 nts of infection, including the oral cavity, peripheral blood lymphocytes, and the cell-free fraction

72 Peak in vivo levels of genetically modified peripheral blood lymphocytes approached 35% +/- 22% (n =

73 NY-ESO-1 was used to transduce CD8-depleted peripheral blood lymphocytes as antigen-presenting cells

74 -Hodgkin's lymphoma (NHL), but not in normal peripheral blood lymphocytes as well as in nonmalignant

75 The results demonstrated that human peripheral blood lymphocytes as well as mouse spleen lym

76 nd gag sequences were PCR amplified from the peripheral blood lymphocytes available from 9 of the 10

77 were measured, and the activation status of peripheral blood lymphocytes bearing mucosal homing mark

78 infusions in sIBM patients depletes not only peripheral blood lymphocytes but also endomysial T cells

79 of normal human thyroid cells and in 21% of peripheral blood lymphocytes, but only in 6% of normal m

80 We examined the phenotype and function of peripheral blood lymphocytes by cell surface or intracel

81 d CD8+ T cells expressing cytokines waned in peripheral blood lymphocytes by day 84, but CD8+ T cell

82 ssion of the early activation marker CD69 in peripheral blood lymphocytes by flow cytometry may provi

83 evels of LOXL1 were determined on c-DNA from peripheral blood lymphocytes by quantitative real-time R

84 (TIL 1383I) and introduced into normal human peripheral blood lymphocytes by retroviral transduction.

85 DNA damage was assessed on peripheral blood lymphocytes by the comet assay before a

86 atedly stimulated with irradiated allogeneic peripheral blood lymphocytes caused the strongest inhibi

87 In contrast, in peripheral blood lymphocytes, CCR9(+) lymphocytes were m

88 Peripheral blood lymphocyte chimerism (WF/ACI) remained

89 This contrasts the data we obtained for peripheral blood lymphocytes collected from the same ani

90 CD8(+) set is readily detected in the human peripheral blood lymphocyte compartment, particularly du

91 ation, oxidative stress, and their impact on peripheral blood lymphocyte composition.

92 rface expression on normal B cells or on any peripheral blood lymphocytes could be detected.

93 , we investigated whether PD-1 expression on peripheral blood lymphocytes could be used as a biomarke

94 0 mg/day produced a significant reduction in peripheral blood lymphocyte count by up to 85%, which re

95 At 1 mg/kg/day, fingolimod decreased both peripheral blood lymphocyte counts and brain Abeta level

96 However, time to normalization of peripheral blood lymphocyte counts and time to complete

97 Median CD4+, CD8+, and CD19+ peripheral blood lymphocyte counts at 73-84 months after

98 Ex vivo analysis of peripheral blood lymphocytes demonstrated enhanced CD16

99 l-characterized breast cell line HCC1395 and peripheral blood lymphocytes derived from the same patie

100 sites such as dorsal root ganglion neurons, peripheral blood lymphocytes, developing thymocytes, and

101 , we addressed whether antiviral response of peripheral blood lymphocytes differs between HG patients

102 fluorescent InsB10-23:DQ8 tetramers, stained peripheral blood lymphocytes directly ex vivo, and show

103 the marrow at neuroblastoma diagnosis or in peripheral blood lymphocyte DNAs of six normal subjects.

104 A. actinomycetemcomitans and DCs to cultured peripheral blood lymphocytes elicited high levels of IFN

105 lines, as well as Sezary Syndrome patients' peripheral blood lymphocytes, exhibited ratio-dependent

106 Peripheral blood lymphocytes express CCR5, a chemokine r

107 on with IL-12/IL-18, monocyte-depleted human peripheral blood lymphocytes expressed the 79-kDa form o

108 We show that, in Jurkat human T cells and peripheral blood lymphocytes, Fas-induced apoptosis is p

109 demonstrate up-regulation of JAM3 protein on peripheral blood lymphocytes following activation.

110 rable engraftment at levels exceeding 10% of peripheral blood lymphocytes for at least 2 months after

111 ) were seen during ITx rejection in archived peripheral blood lymphocyte from test and replication co

112 Each of 2 aliquots of peripheral blood lymphocytes from 4 rhesus monkeys were

113 Peripheral blood lymphocytes from 41 hemodialysis patien

114 Mutagen sensitivity was measured in peripheral blood lymphocytes from 460 individuals [148 p

115 -gamma ELISPOT and cytotoxicity assays using peripheral blood lymphocytes from 66 HBV-infected patien

116 l RNA isolated from Tat- and vehicle-treated peripheral blood lymphocytes from a healthy donor showed

117 of CD4(+) T-cell clones were generated from peripheral blood lymphocytes from a patient with a nonpr

118 generation and DNA damage, freshly prepared peripheral blood lymphocytes from all three groups were

119 ing of Tax11-19/HLA-A*0201 tetramer-positive peripheral blood lymphocytes from an HTLV-1-infected ind

120 by PCR-based genome walking using uncultured peripheral blood lymphocytes from an HTLV-3-infected per

121 CTL activity to allogeneic paternal cells in peripheral blood lymphocytes from both horse mares and d

122 dendritic cells (DCs) were used to stimulate peripheral blood lymphocytes from cervical cancer patien

123 The extent of endogenous DNA damage in peripheral blood lymphocytes from dogs given the dietary

124 Short-term cultured peripheral blood lymphocytes from each subject were expo

125 Peripheral blood lymphocytes from elephants, healthy hum

126 s between human leukocyte antigen-mismatched peripheral blood lymphocytes from healthy adults.

127 mRNA TCR engineering of peripheral blood lymphocytes from healthy donors or chro

128 al lipids was analyzed in ex vivo studies of peripheral blood lymphocytes from human patients with pu

129 ified beta-galactosidase and showed that the peripheral blood lymphocytes from in utero-transduced sh

130 Here, we used fresh peripheral blood lymphocytes from individual subjects un

131 tained behavioural data, plasma samples, and peripheral blood lymphocytes from individuals living in

132 and breast cancer cell lines, as well as by peripheral blood lymphocytes from lymphoma patients, can

133 during T-cell receptor-mediated apoptosis in peripheral blood lymphocytes from normal donors.

134 r cells (CD34+) and interleukin-2-stimulated peripheral blood lymphocytes from normal healthy donors

135 assessed the functional responses to IFN in peripheral blood lymphocytes from patients with 3 major

136 ine deaminase (ADA) cDNA to transduce mature peripheral blood lymphocytes from patients with ADA defi

137 ponses against six cancer-testis antigens in peripheral blood lymphocytes from patients with esophage

138 (2) and its possible effect on DNA damage in peripheral blood lymphocytes from patients with vitiligo

139 iated lysis (range: 52-100% inhibition) when peripheral blood lymphocytes from seven healthy donors,

140 After CD3/CD28 activation, peripheral blood lymphocytes from SSc patients produced

141 8 beads with higher frequency than activated peripheral blood lymphocytes from the same patients.

142 Peripheral blood lymphocytes from these subjects were an

143 No peripheral blood lymphocytes from three HLA-2.1+ donors

144 In vitro assays demonstrated that peripheral blood lymphocytes from tolerant animals produ

145 tramer-binding CD8+ T cells were detected in peripheral blood lymphocytes from two of six patients af

146 However, routine peripheral blood lymphocyte gamma interferon enzyme-link

147 nduced by mutagens in short-term cultures of peripheral blood lymphocytes, has been used as an indire

148 d (low-load carriers, 8 to 200 genomes/10(5) peripheral blood lymphocytes; high-load carriers, >200 g

149 ility and genome damage in the primary human peripheral blood lymphocytes (HPBLs) and exhibited free

150 efficacy in HIV-1-infected humanized [human peripheral blood lymphocyte (Hu-PBL)] mice by completely

151 icient mice that were repopulated with human peripheral blood lymphocytes (hu-PBL-NOD/SCID mice).

152 d immunodeficient murine recipients of human peripheral-blood lymphocytes (hu-PBL-SCID).

153 The genome-scale DNA methylation profiles of peripheral blood lymphocytes in cows with S. aureus subc

154 nses were quantitated using freshly isolated peripheral blood lymphocytes in direct lytic assays as w

155 mph node compartments was similar to that in peripheral blood lymphocytes in individual monkeys.

156 Proliferation of healthy donor peripheral blood lymphocytes in response to IL-2 was inh

157 f relying on immunological measurements from peripheral blood lymphocytes in studies of protective im

158 and could be transmitted from macrophages to peripheral blood lymphocytes in trans 6 weeks after ongo

159 quinone-mediated DNA damage by estrogens in peripheral blood lymphocytes in vitiligo.

160 To address this issue, we irradiated human peripheral blood lymphocytes in vitro with 0.5 Gy densel

161 upregulation of tetherin (BST-2 or CD317) on peripheral blood lymphocytes, including the CD4(+) CCR5(

162 Depletion of peripheral blood lymphocytes, including the naive and me

163 us is frequently detected in squirrel monkey peripheral blood lymphocytes, indicating that persistent

164 The cytotoxicity for human peripheral blood lymphocytes is extremely low (>100 muM)

165 ssociated loss of telomere length in vivo in peripheral blood lymphocytes is specific to T and B cell

166 y various mutagens in short-term cultures of peripheral blood lymphocytes, is an established risk fac

167 n immediate depletion or severe reduction of peripheral blood lymphocytes, lasting at least 6 months.

168 xicity of dexamethasone against nonmalignant peripheral blood lymphocytes, mesenchymal stromal cells,

169 rm of MIP-1 beta secreted by activated human peripheral blood lymphocytes (MIP-1 beta(3-69)) lacks th

170 t lengths and FMR1 mRNA expression levels in peripheral blood lymphocytes, motor functioning, and whi

171 We found that human peripheral blood lymphocytes not only provide lytic sign

172 le-chain Fv (scFv) antibody library from the peripheral blood lymphocytes of 20 patients with various

173 al instability, we used FISH to evaluate the peripheral blood lymphocytes of 22 PBSC donors and 22 ma

174 a measure of recent thymic emigrant cells in peripheral blood lymphocytes of 50 HIV-infected infants

175 and markedly decreased protein expression in peripheral blood lymphocytes of affected patients.

176 ng motif, was used to generate CTLs from the peripheral blood lymphocytes of an HLA-A1+ healthy donor

177 essful heterohybridoma immortalized from the peripheral blood lymphocytes of an infertile woman who e

178 NY-ESO-1-specific CD8+ and CD4+ T cells from peripheral blood lymphocytes of cancer patients in vitro

179 ome; we identified 2410 integration sites in peripheral blood lymphocytes of five infected individual

180 CD30(+) T lymphocytes were increased in peripheral blood lymphocytes of melanoma patients at adv

181 the interpretation of measurements made with peripheral blood lymphocytes of multiple sclerosis patie

182 type and Th2-type CD4+ T-cell responses from peripheral blood lymphocytes of normal donors and melano

183 inducing specific CD4+ T cells in vitro from peripheral blood lymphocytes of normal donors and patien

184 I) Tax11-19 peptide-specific CD8(+) cells in peripheral blood lymphocytes of patients with HTLV-I-ass

185 Spleens, lymph nodes, and peripheral blood lymphocytes of secondary tolerant recip

186 substitutions in variable VH6 genes from the peripheral blood lymphocytes of three patients with xero

187 e target DNA sequences as small as 50 nts in peripheral blood lymphocytes or in stretched DNA fibers.

188 id tumors, accessible normal tissues such as peripheral blood lymphocytes or, perhaps more germane to

189 enriched TILs had significantly fewer CD4(+) peripheral blood lymphocytes (P = .01).

190 In peripheral blood lymphocytes, papain cleaved off HLA cla

191 erforming genomewide bisulfite sequencing in peripheral blood lymphocyte (PBL) and hair follicle DNA

192 2) standard miniature swine; and 3) GalT-KO peripheral blood lymphocytes (PBL) and cultured endothel

193 ssed by an interferon gamma ELIspot assay in peripheral blood lymphocytes (PBL) and in a lymph node d

194 ercent of mice with >20% of CD4+ cells among peripheral blood lymphocytes (PBL) by 13 weeks posttrans

195 tion of IFN by phytohemagglutinin-stimulated peripheral blood lymphocytes (PBL) compared to Edmonston

196 SAHA in CTCL cell lines and freshly isolated peripheral blood lymphocytes (PBL) from CTCL patients wi

197 colonic lamina propria lymphocytes (LPL) and peripheral blood lymphocytes (PBL) from healthy individu

198 When responding peripheral blood lymphocytes (PBL) from normal volunteer

199 nes (MJ, Hut78, and HH) and freshly isolated peripheral blood lymphocytes (PBL) from SS patients with

200 DNA PCR levels, defined as >/=40 genomes/105 peripheral blood lymphocytes (PBL) in pretransplant EBV-

201 CR for imprinting analysis of IGF2 on normal peripheral blood lymphocytes (PBL) of individuals.

202 omic sequences are readily detectable in the peripheral blood lymphocytes (PBL) of seropositive indiv

203 ared the characteristics of fresh RCC TIL to peripheral blood lymphocytes (PBL) or melanoma TIL.

204 The reduced ability of Vgamma2Vdelta2(+) peripheral blood lymphocytes (PBL) to expand could be re

205 We found that treatment of peripheral blood lymphocytes (PBL) with methyl-beta-cycl

206 ve been successfully treated with autologous peripheral blood lymphocytes (PBL), genetically modified

207 CR3 expressed in recombinant cells and human peripheral blood lymphocytes (PBL).

208 ) enzyme-linked immunospots (ELISPOTS)/10(6) peripheral blood lymphocytes (PBL).

209 ileum, mesenteric lymph nodes [MLN], spleen, peripheral blood lymphocytes [PBL], and bone marrow lymp

210 specimens (6 PBC and 6 controls), and fresh peripheral blood lymphocytes (PBLs) (10 PBC and 10 contr

211 sma (n = 59) by TaqMan PCR and in samples of peripheral blood lymphocytes (PBLs) (n = 60) by competit

212 cks to the early phase of HIV-1 infection in peripheral blood lymphocytes (PBLs) and a B lymphocytic

213 or-promoting phorbol ester, on primary human peripheral blood lymphocytes (PBLs) and assessed its abi

214 ominant-negative form of CDK9 (HA-dnCDK9) in peripheral blood lymphocytes (PBLs) and other cells.

215 secreted from activated human monocytes and peripheral blood lymphocytes (PBLs) as a heterodimer.

216 icted in phytohemagglutinin (PHA)-stimulated peripheral blood lymphocytes (PBLs) but proceeded effici

217 13+ (IL-13+) T cells (CD4+ or CD8+) in human peripheral blood lymphocytes (PBLs) can respond directly

218 were examined by mRNA transfection of human peripheral blood lymphocytes (PBLs) derived from healthy

219 Peripheral blood lymphocytes (PBLs) from healthy donors

220 firm the specific expression of T-plastin in peripheral blood lymphocytes (PBLs) from SS patients and

221 Peripheral blood lymphocytes (PBLs) from systemic lupus

222 nsplant patient who developed KS and in whom peripheral blood lymphocytes (PBLs) had been prospective

223 nyl-coenzyme A carboxylase (PCC) activity in peripheral blood lymphocytes (PBLs) is a sensitive indic

224 In the peripheral blood lymphocytes (PBLs) of a separate group

225 Infection of CCR5(-) human peripheral blood lymphocytes (PBLs) showed that 2 differ

226 Baseline studies were performed on peripheral blood lymphocytes (PBLs) vs. marrow in normal

227 le gene expression in human T cells, primary peripheral blood lymphocytes (PBLs) were nucleofected wi

228 Peripheral blood lymphocytes (PBLs) were treated in vitr

229 responses generated in vitro against patient peripheral blood lymphocytes (PBLs) with those detected

230 Thus, in human peripheral blood lymphocytes (PBLs), approximately 1-4%

231 can be successfully reconstituted with human peripheral blood lymphocytes (PBLs), but rates and level

232 However, for human peripheral blood lymphocytes (PBLs), this is generally r

233 Y-ESO-1-specific CD8(+) T cells derived from peripheral blood lymphocytes (PBLs), tumor-infiltrating

234 althy subjects express <1 NKT cell per 1,000 peripheral blood lymphocytes (PBLs), we devised a new me

235 potent CD4+ T-cell antigens, using patients' peripheral blood lymphocytes (PBLs).

236 rnal-beam ionizing radiation-induced DSBs in peripheral blood lymphocytes (PBLs).

237 respectively by PMA and PHA in primary human peripheral blood lymphocytes (PBLs).

238 ing both a test substrate (casein) and fresh peripheral blood lymphocytes (PBLs).

239 a ELIspot assay (Chiron, Emeryville, CA), in peripheral-blood lymphocytes (PBLs) and in a lymph node

240 tumors and phosphorylation of ERK (pERK) in peripheral-blood lymphocytes (PBLs) before and after 1 m

241 Lesional skin biopsy specimens and peripheral blood lymphocyte phenotype were analyzed.

242 ive SLE and to correlate these findings with peripheral blood lymphocyte phenotypes.

243 , SOCE measurements, immunologic analysis of peripheral blood lymphocyte populations by using flow cy

244 pansion of both rabbit splenocytes and human peripheral blood lymphocytes, preferentially expanded hu

245 CCR5 internalization, and individuals whose peripheral blood lymphocytes produce high levels of thes

246 prisingly exhibit increased bioactivity in a peripheral blood lymphocyte proliferation assay.

247 odulatory functions, specifically suppressed peripheral blood lymphocyte proliferation, induced expre

248 T helper (interleukin-5- and -10-producing) peripheral blood lymphocytes reactive with a panel of sy

249 stration of the prodrug 14 induces sustained peripheral blood lymphocyte reduction in rats.

250 Normal human peripheral blood lymphocytes resisted salinomycin toxici

251 n combination with flow cytometry to compare peripheral blood lymphocyte responses of cattle with sub

252 Flow cytometry of peripheral blood lymphocytes revealed dramatic efflux of

253 In vitro experiments with human peripheral blood lymphocytes revealed that pirfenidone r

254 ll three PCR assays gave negative results on peripheral blood lymphocyte samples from 69 humans, as w

255 Matched urine and peripheral blood lymphocyte samples were obtained before

256 for coreceptor switch variants in the human peripheral blood lymphocyte-SCID mouse model.

257 va, rectal brushings, rectal swab specimens, peripheral blood lymphocytes, semen, and urine) from hum

258 -17D-induced clones could be identified from peripheral blood lymphocytes solely by measuring clonal

259 ction, prospectively collected cryopreserved peripheral-blood lymphocyte specimens (n = 90) from the

260 TBX21 expression was detected in peripheral blood lymphocytes, spleen, lung, and natural

261 meras showed deletion of donor-reactive CD4+ peripheral blood lymphocytes, splenocytes, and mature th

262 ymphocyte reaction (MLR) responses of normal peripheral blood lymphocytes stimulated with irradiated

263 interleukin(IL)-2 expression by normal human peripheral blood lymphocytes stimulated with phorbol 12-

264 (TCR)/CD3 complex in either Jurkat cells or peripheral blood lymphocytes stimulates phosphorylation

265 s identified within certain Vbeta-expressing peripheral blood lymphocyte subpopulations in the infect

266 erum immunoglobulins and complement factors, peripheral blood lymphocyte subpopulations, and whole bl

267 Peripheral blood lymphocyte subsets were analyzed by flo

268 compared their gene expression profiles and peripheral blood lymphocyte subsets with those of subjec

269 can also be conveyed from NHOKs to activated peripheral blood lymphocytes, suggesting a potential rol

270 shown to be mosaic for the FLN1 mutation in peripheral blood lymphocytes, suggesting that some neuro

271 es apoptosis in CLL cells, but not in normal peripheral blood lymphocytes, suggesting the involvement

272 ent mice reconstituted with 50 x 10(6) human peripheral blood lymphocytes) that received three biweek

273 nse to oral prednisolone, and sensitivity of peripheral blood lymphocytes to corticosteroids were mea

274 DNA cells, the dendritic cells primed normal peripheral blood lymphocytes to generate effector T cell

275 e alpha1 helix, were presented by autologous peripheral blood lymphocytes to induce T-cell proliferat

276 igen-presenting cells, we stimulated patient peripheral blood lymphocytes to isolate peptide-specific

277 culosis strain H37Rv in which the ability of peripheral blood lymphocytes to limit intracellular grow

278 er, we analyzed their expression patterns in peripheral blood lymphocytes using Pacific Biosciences (

279 , immortalized B-cells, cultured T-cells and peripheral blood lymphocytes using reverse transcriptase

280 fication of genomic DNA from miniature swine peripheral blood lymphocytes, using primers correspondin

281 in reaction (PCR), and protein expression in peripheral blood lymphocytes was analyzed by flow cytome

282 or T-cell response, the T-cell repertoire of peripheral blood lymphocytes was assessed by complementa

283 r expression on CD4+,CD28- T cell clones and peripheral blood lymphocytes was assessed by multicolor

284 Reactivation of the rMd5DeltaMeq virus from peripheral blood lymphocytes was reduced, suggesting tha

285 Peripheral blood lymphocytes were analysed by flow cytom

286 Peripheral blood lymphocytes were analysed by flow cytom

287 telomere length and telomerase expression in peripheral blood lymphocytes were analyzed from 121 norm

288 Peripheral blood lymphocytes were collected at the time

289 Viral loads >200 genome copies/10(5) peripheral blood lymphocytes were considered consistent

290 Peripheral blood lymphocytes were cultured for 90 hours,

291 Sequentially collected peripheral blood lymphocytes were examined with a recent

292 e who were seropositive) genome copies/10(5) peripheral blood lymphocytes were felt to identify patie

293 Rat PMNs and peripheral blood lymphocytes were isolated by density ce

294 Peripheral blood lymphocytes were isolated from 117 stab

295 Peripheral blood lymphocytes were isolated, ethanol-fixe

296 Fresh human peripheral blood lymphocytes were used as NK effector ce

297 The recipients' peripheral-blood lymphocytes were collected before myelo

298 evels of genotoxicity following treatment of peripheral blood lymphocytes with complex 9, suggesting

299 AD(+) levels were increased by supplementing peripheral blood lymphocytes with the NAD(+) precursors

300 ayed a dose-dependent, reversible decline in peripheral blood lymphocytes without an enhanced inciden